|
|
|
For
details of shares issued, please
visit our Share
Price and RNS page.
Major
shareholders (including Directors)
As of 23rd January 2012 shareholders holding more than 3% of the share capital in Mediwatch Plc were: |
|
| TR1 notifications |
|
| Mr.
Philip G Stimpson |
16.61% |
| Charles Stanley |
5.04% |
| David Knox |
3.20% |
| Brewin Dolphin |
3.24% |
| Director Shareholding |
|
| Philip Stimpson |
16.61% |
| Omer Karim |
7.00% |
| Mark Emberton |
1.86% |
| Colm Croskery |
0.93% |
| Charles Cattaneo |
0.99% |
| Share Register Analysis as at 23rd January 2012 over 3% |
|
| Barclays Stockbrokers |
9.90% |
| Forward Group |
4.74% |
| Ashcourt Nominees |
4.67% |
| HSDL Nominees Ltd |
4.10% |
| Harbour Ltd |
3.70% |
| Rock Nominees |
6.10% |
| LR Nominees |
6.10% |
| TD Direct Investing Nominees (Europe) Ltd |
6.30% |
| |
|
| "In so far as Mediwatch is aware, 26.04% of the company's shares are not in public hands" (as defined in the AIM Rules) and there are no restrictions on the transfer of the company's AIM securities. |
|
|
|
|
|
|
|
